Increased <scp>RUNX3</scp> expression mediates tumor‐promoting ability of human breast cancer‐associated fibroblasts
Yu Koyama(Tokyo Dental College), Akira Orimo(University of Manchester), Akane Ishizuka(Juntendo University), Reo Maruyama(Brigham and Women's Hospital), Takumi Koyama(Tokyo Dental College), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization), Liying Yang(Japanese Foundation For Cancer Research), Yang Shi(University of Victoria), Toshinari Yamashita(Kanagawa Prefectural Hospital Organization), Okio Hino(Juntendo University), Yoshihiro Mezawa(Juntendo University), Yasuhiko Ito(Aichi Medical University), Takehiro Yasukawa(Juntendo University), Yohei Miyagi(Kanagawa Cancer Center), Keisuke Sugahara(Tokyo Dental College), Akira Katakura(Tokyo Dental College), Zixu Wang(Dana-Farber Cancer Institute), Atsushi Takano(The University of Tokyo), Hiroya Okazaki(Tokyo Dental College), Mizuki Sakimoto(Juntendo University), Yataro Daigo(The University of Tokyo)
Cited by 9
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Autophagy-deficient mice develop multiple liver tumors
|Genes & Development|2011|1.3k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593